期刊文献+

细针穿刺洗脱液甲状旁腺激素测定诊断原发性甲状旁腺功能亢进病灶的临床研究 被引量:2

Clinical study on the diagnosis of primary hyperparathyroidism lesions with parathyroid hormone assay in fine needle aspiration washout
原文传递
导出
摘要 目的探讨细针穿刺(FNA)洗脱液甲状旁腺激素(PTH)测定(FNA-PTH)对原发性甲状旁腺功能亢进病灶(HPTL)的诊断价值。方法选择2018年10月至2023年2月经颈部超声检出可疑甲状旁腺病变的患者,结合血PTH、核素显像、术后病理结果判定HPTL,分析FNA-PTH对HPTL的诊断效能,并构建合理的诊断切点。结果本研究共纳入94例患者、98个结节,其中76例患者(80个结节)接受了FNA检查。HPTL与非HPTL的FNA-PTH中位数分别为2396.50 pg/ml(Q1~Q3:878.08~5000.00 pg/ml)、21.98 pg/ml(16.04~32.16 pg/ml),FNA-PTH/血清PTH比值(PTH比值)中位数分别为12.47(4.89~29.43)、0.62(0.45~0.79),差异均有统计学意义(P值均<0.001)。ROC曲线显示FNA-PTH测值的AUC略高于PTH比值(0.937比0.849)。以187.90 pg/ml作为FNA-PTH的诊断界值时敏感性为88.9%,特异性与准确性均为90.9%,与PTH比值无统计学差异(P=1.0)。结论FNA-PTH检测对HPTL具有很高的定位与诊断价值,以187.90 pg/ml作为诊断切点效能最佳。 Objective To investigate the diagnostic value of parathyroid hormone measurement in fine needle aspiration washout(FNA-PTH)in primary hyperparathyroidism lesions(HPTLs).Methods Patients with suspected parathyroid lesions detected by neck ultrasonography from October 2018 to February 2023 were selected,and HPTL was determined based on serum parathyroid hormone(PTH),radionuclide imaging,and postoperative pathological results.The diagnostic value of FNA-PTH on HPTL was analyzed,and an effective diagnostic cut-off point was also established.Results A total of 94 patients and 98 nodules were enrolled in this study,of which 76 patients(80 nodules)underwent FNA.The median values of FNA-PTH for HPTLs and non-HPTLs were 2396.50 pg/ml(878.08-5000.00 pg/ml),21.98 pg/ml(16.04-32.16 pg/ml),and FNA-PTH/serum PTH(PTH ratio)were 12.47(4.89-29.43)and 0.62(0.45-0.79),respectively;the differences were statistically significant(all P<0.001).The ROC curve showed that the AUC of the FNA-PTH value was slightly higher than the PTH ratio(0.937 vs 0.849).Taking 187.90 pg/ml as the diagnostic cut-off value,the sensitivity,specificity,and accuracy of FNA-PTH were 88.9%,90.9%,and 90.0%,respectively.The efficacy was slightly better than the PTH ratio without statistical difference.Conclusions FNA-PTH testing is of great value in the localization and diagnosis of HPTL,with 187.90pg/ml as the optimal diagnostic cut-off.
作者 张于芝 丁文波 武心萍 徐书杭 刘超 Zhang Yuzhi;Ding Wenbo;Wu Xinping;Xu Shuhang;Liu Chao(Department of Ultrasound,Affiliated Hospital of Integrated Traditional Chinese and Western Medicine,Nanjing University of Chinese Medicine,Nanjing 210028,China;Endocrine and Diabetes Center,Affiliated Hospital of Integrated Traditional Chinese and Western Medicine,Nanjing University of Chinese Medicine,Nanjing 210028,China)
出处 《国际内分泌代谢杂志》 2024年第1期14-18,共5页 International Journal of Endocrinology and Metabolism
基金 2020年江苏省重点研发计划(BE2020726),中华国际医学交流基金会甲状腺中青年医生研究项目(BQE-JZX-202115),江苏省卫生健康委2020年度医学科研项目(M2020102)。
关键词 原发性甲状旁腺功能亢进症 甲状旁腺激素 细针穿刺 洗脱液 超声 Primary hyperparathyroidism Parathyroid hormone Fine needle aspiration Washout Ultrasound
  • 相关文献

参考文献1

二级参考文献14

  • 1孟迅吾,沙利进.原发性甲状旁腺功能亢进症[M]//史轶蘩.协和内分泌代谢学.北京:科学出版社,1999:1464-1477.
  • 2廖二元.原发性甲状旁腺功能亢进症[M]//廖二元,曹旭.湘雅代谢性骨病学.北京:科学出版社,2003:660-700.
  • 3孟迅吾,王鸥.原发性甲状旁腺功能亢进症[M]//陈家伦.临床内分泌学.上海:上海科学技术出版社,2011:1365-1370.
  • 4Silverberg SJ.Primary hyperparathyroidism[M]//Rosen CJ.Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.8th ed.Danvers,MA01923,USA:A John Wiley&Sons,2013:543-552.
  • 5Bringhurst FR,Demay MB,Kronenberg HM.Hormones and disorders of mineral metabolism[M]//Kronenberg HM.Williams Textbook of Endocrinology.11th ed.Philadelphia:Saunders Elsevier,2008:1203-1268.
  • 6Zhao L,Liu JM,He XY,et al.The changing clinical patterns of primary hyperparathyroidism in Chinese patients:data from 2000 to 2010 in a single clinical center[J].J Clin Endocrinol Metab,2013,98:721-728.
  • 7Sharretts JM,Simonds WF.Clinical and molecular genetics of parathyroid neoplasms[J].Best Pract Res Clin Endocrinol Metab,2010,24;491-502.
  • 8Arnold A,Marx SJ.Familial primary hyperparathyroidism[M]//Rosen CJ.Primer on the metabolic bone diseases and disorders of mineral metabolism.8th ed.Danvers,MA01923,USA:A John Wiley&Sons,2013:553-561.
  • 9Bilezikian JP,Khan AA,Potts JT Jr,et al.Guidelines for the management of asymptomatic primary hyperparathyroidism:summary statement from the thirdinternational workshop[J].J Clin Endocrinol Metab,2009,94:335-339.
  • 10Marcocci C,Cetani F.Clinical practice.Primary hyperparathyroidism[J].N Engl J Med,2011,365:2389-2397.

共引文献151

同被引文献25

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部